3:45 pm Roundtable Discussion: Combining MASH Therapies to Investigate Combination & Sequential Approaches to Effectively Treat the Differing Stages of MASH
Time: 3:45 pm
day: Combination & Sequential Therapy Focus Day
Details:
- Discussing combination therapy rationale to offer a strategic advantage by simultaneously targeting the multiple pathogenic pathways of MASH, addressing steatosis, inflammation, and fibrosis to optimize synergistic effects and improve treatment outcomes compared to monotherapies
- Highlighting sequential therapy to achieve initial therapeutic goals like steatosis reduction before addressing other disease aspects, and minimize potential toxicity to optimize the risk-benefit profile of MASH treatment
- Emphasizing precision medicine in MASH to gain a deeper understanding of the genetic and molecular heterogeneity of MASH to tailored combination and sequential approaches that can maximize individual patient response
